Activating Transposon Identifies Antibiotic Targets

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods, such as Tn-seq, struggle to identify essential genes serving as antibiotic targets in bacteria due to transposon insertions not being significantly represented in the initial mutant pool, making it difficult to distinguish between essential genes and antibiotic targets.

Innovation Solution

A method using an activating transposon (TnA) that increases gene transcription upon insertion, allowing for the identification of essential genes as antibiotic targets by comparing transposon insertion distributions in bacterial cultures grown with varying antibiotic concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional Tn-seq methods are used to identify antibiotic targets, then the method can identify genes advantageous for growth, but it cannot identify essential genes serving as antibiotic targets because transposon insertions into essential genes are not significantly represented in the initial mutant pool

Engineering Contradiction:
Improveidentification accuracy of antibiotic targetsVSAvoidability to distinguish essential genes from antibiotic targets
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent inverts the conventional Tn-seq approach by using an activating transposon that increases gene transcription upon insertion, rather than simply inactivating genes. This inversion allows essential genes to be represented in the mutant pool through increased transcriptional activity, enabling their identification as antibiotic targets through changes in transposon distribution patterns when grown with antibiotics.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent changes the functional parameter of the transposon from gene inactivation to gene activation. The activating transposon (TnA) carries a promoter that increases transcription of the inserted gene, fundamentally altering how transposon insertions are detected and interpreted in the context of antibiotic target identification.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If transposon insertions into essential genes are not represented in the initial mutant pool, then the mutant pool can be maintained, but essential genes serving as antibiotic targets cannot be identified

Engineering Contradiction:
Improvethroughput of antibiotic target identificationVSAvoidinformation about essential gene targets
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent implements feedback by comparing transposon distribution patterns between control and antibiotic-treated cultures. The activating transposon creates a detectable signal through increased transcription that provides feedback about essential gene targets, allowing identification of antibiotic targets through changes in distribution patterns rather than relying on initial mutant pool composition.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach ensures transposon insertions into essential genes are represented, enabling the identification of antibiotic targets by analyzing changes in transposon distribution, thereby determining the effect of antibiotics on gene targets.

Implementation Method 1

the TnA comprises a promoter such that transposon insertion into bacterial DNA increases the transcription of a gene at or near the insertion site

Methodology Applied
Scientific EffectTranscription:

Data Source

PatentUS20220186211A9Method for identifying antibiotic targets
Publication Date: 2022.06.16 DISCUVA
  • US20220186211A9 patent drawing
  • US20220186211A9 patent drawing
  • US20220186211A9 patent drawing

AI summary

Disclosed are methods related to identifying an essential gene which serves as an antibiotic target in a bacterium.